H35.05
Retinal neovascularization, unspecified
Clinical Classification Guidelines
Medical Intelligence & Overview
Retinal neovascularization refers to the abnormal growth of new blood vessels on the retina, the light-sensitive tissue at the back of the eye. This condition is often associated with various eye diseases and can impair vision if left untreated. The ICD-10 code H35.05 categorizes this condition as unspecified, indicating that the precise type or cause of neovascularization has not been detailed.
Causes & Symptoms
Clinical Causes: Diabetic retinopathy, especially proliferative diabetic retinopathy Lacteal occlusion or ischemia from conditions like central retinal vein occlusion Retinal vein or artery occlusion Age-related macular degeneration (especially wet type) Inflammatory eye diseases such as uveitis Sickle cell disease affecting the eye Previous retinal injuries or trauma High blood pressure leading to retinal ischemia
Key Symptoms: Sudden or gradual loss of vision Blurred or distorted vision Appearance of floaters or dark spots in the field of vision Visual distortion or shapes that are wavy Reduced visual acuity over time
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a comprehensive eye examination, including dilated fundus examination using specialized equipment like ophthalmoscopes. Imaging tests such as fluorescein angiography are employed to visualize abnormal blood vessels and determine their location and extent. Optical coherence tomography (OCT) can also be used to assess retinal thickness and detect fluid accumulation.
Treatment Protocols: Treatment approaches aim to prevent vision loss by managing abnormal blood vessel growth and underlying causes. Common options include: - Laser photocoagulation therapy to cauterize abnormal vessels - Intravitreous injections of anti-VEGF agents to inhibit vessel growth - Corticosteroid injections to reduce inflammation - Surgical procedures like vitrectomy in advanced cases - Managing related systemic conditions such as diabetes and hypertension to control progression
Clinical Advice & FAQs
Billing Guidance
Is H35.05 a billable ICD-10 code?
Yes, H35.05 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H35.05?
Clinical documentation must specify the nature of Retinal neovascularization, unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference